|
| | Publication Year | Title | Author(s) |
| 321 | Apr-2019 | Osimertinib as first-line (1L) treatment for epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC): Final efficacy and safety results from two phase I expansion cohorts. | Yang, J C-H; Ramalingam, S S; Lee, C K; Kurata, T; Kim, D-W; John, Thomas ; Nogami, N; Ohe, Y; Rukazenkov, Y; Murphy, M; Jänne, P A |
| 322 | 2018 | Osimertinib as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer | Ramalingam, Suresh S; Yang, James C-H; Lee, Chee Khoon; John, Thomas ; Kurata, Takayasu; Nogami, Naoyuki; Ohe, Yuichiro; Kim, Dong-Wan; Mann, Helen; Rukazenkov, Yuri; Ghiorghiu, Serban; Stetson, Daniel; Markovets, Aleksandra; Barrett, J Carl; Thress, Kenneth S; Jänne, Pasi A |
| 323 | Oct-2020 | Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. | Wu, Yi-Long; Tsuboi, Masahiro; He, Jie; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S |
| 324 | Nov-2020 | Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. | Papadimitrakopoulou, V A; Mok, T S; Han, J-Y; Ahn, M-J; Delmonte, A; Ramalingam, S S; Kim, S W; Shepherd, F A; Laskin, J; He, Y; Akamatsu, H; Theelen, W S M E; Su, W-C; John, Thomas ; Sebastian, M; Mann, H; Miranda, M; Laus, G; Rukazenkov, Y; Wu, Y-L |
| 325 | Apr-2018 | Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study. | Wann, Alysson ; Tully, Patrick A; Barnes, Elizabeth H; Lwin, Zarnie; Jeffree, Rosalind; Drummond, Katharine J; Gan, Hui K ; Khasraw, Mustafa |
| 326 | Aug-2017 | Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer. | Tamjid, Babak ; Phan, Phuong L; John, Thomas ; Mitchell, Paul L R ; Gan, Hui K |
| 327 | 12-Nov-2021 | Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trial. | Field, K M; Barnes, E H; Sim, H W; Nowak, A K; Simes, J; Rosenthal, M A; Wheeler, H; Hovey, E J; Cher, Lawrence M |
| 328 | Mar-2019 | Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20. | Wells, J Connor; Tu, Dongsheng; Siu, Lillian L; Shapiro, Jeremy D; Jonker, Derek J; Karapetis, Christos; Simes, John; Liu, Geoffrey; Price, Timothy J; Tebbutt, Niall C ; O'Callaghan, Chris J |
| 329 | 28-Nov-2018 | Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20. | Wells, J Connor; Tu, Dongsheng; Siu, Lillian L; Shapiro, Jeremy D; Jonker, Derek J; Karapetis, Christopher S; Simes, John; Liu, Geoffrey; Price, Timothy J; Tebbutt, Niall C ; O'Callaghan, Chris J |
| 330 | 2020 | Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC. | Ramalingam, Suresh S; Vansteenkiste, Johan; Planchard, David; Cho, Byoung Chul; Gray, Jhanelle E; Ohe, Yuichiro; Zhou, Caicun; Reungwetwattana, Thanyanan; Cheng, Ying; Chewaskulyong, Busyamas; Shah, Riyaz; Cobo, Manuel; Lee, Ki Hyeong; Cheema, Parneet; Tiseo, Marcello; John, Thomas ; Lin, Meng-Chih; Imamura, Fumio; Kurata, Takayasu; Todd, Alexander; Hodge, Rachel; Saggese, Matilde; Rukazenkov, Yuri; Soria, Jean-Charles |
| 331 | Mar-2020 | Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. | Williams, David S ; Mouradov, Dmitri; Browne, Clare; Palmieri, Michelle; Elliott, Meg J; Nightingale, Rebecca; Fang, Catherine G; Li, Rita; Mariadason, John M ; Faragher, Ian; Jones, Ian T; Churilov, Leonid ; Tebbutt, Niall C ; Gibbs, Peter; Sieber, Oliver M |
| 332 | 3-Dec-2013 | Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. | Greenhalf, William; Ghaneh, Paula; Neoptolemos, John P; Palmer, Daniel H; Cox, Trevor F; Lamb, Richard F; Garner, Elizabeth; Campbell, Fiona; Mackey, John R; Costello, Eithne; Moore, Malcolm J; Valle, Juan W; McDonald, Alexander C; Carter, Ross; Tebbutt, Niall C ; Goldstein, David B; Shannon, Jennifer; Dervenis, Christos; Glimelius, Bengt; Deakin, Mark; Charnley, Richard M; Lacaine, François; Scarfe, Andrew G; Middleton, Mark R; Anthoney, Alan; Halloran, Christopher M; Mayerle, Julia; Oláh, Attila; Jackson, Richard; Rawcliffe, Charlotte L; Scarpa, Aldo; Bassi, Claudio; Büchler, Markus W |
| 333 | Mar-2016 | Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial | Tebbutt, Niall C ; Price, Timothy J; Ferraro, Danielle A; Wong, Nicole; Veillard, Anne-Sophie; Hall, Merryn; Sjoquist, Katrin M; Pavlakis, Nick; Strickland, Andrew; Varma, Suresh C; Cooray, Prasad; Young, Rosemary; Underhill, Craig; Shannon, Jennifer A; Ganju, Vinod; Gebski, Val J |
| 334 | 4-May-2022 | Paracrine IL-6 Signaling Confers Proliferation between Heterogeneous Inflammatory Breast Cancer Sub-Clones. | Morrow, Riley J; Allam, Amr H; Yeo, Belinda ; Deb, Siddhartha; Murone, Carmel ; Lim, Elgene; Johnstone, Cameron N ; Ernst, Matthias |
| 335 | 31-Aug-2012 | Paraneoplastic leukocytoclastic vasculitis as an initial presentation of malignant pleural mesothelioma: a case report. | Wong, Shu Fen; Newland, Lisa; John, Thomas ; White, Shane C |
| 336 | 15-Feb-2017 | Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma. | Wu, Licun; Allo, Ghassan; John, Thomas ; Li, Ming; Tagawa, Tetsuzo; Opitz, Isabelle; Anraku, Masaki; Yun, Zhihong; Pintilie, Melania; Pitcher, Bethany; Liu, Geoffrey; Feld, Ron; Johnston, Michael R; de Perrot, Marc; Tsao, Ming-Sound |
| 337 | 7-Aug-2023 | Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study. | Huang, Joanna; Faisal, Wasek; Brand, Margaret; Smith, Shantelle; Alexander, Marliese; Briggs, Lisa; Conron, Matthew; Duffy, Mary; John, Thomas ; Langton, David; Lesage, Jacqueline; MacManus, Michael; Mitchell, Paul L R ; Olesen, Inger; Parente, Phillip; Philip, Jennifer; Samuel, Evangeline; Torres, Javier; Underhill, Craig R; Zalcberg, John R; Harden, Susan; Stirling, Rob |
| 338 | 22-Apr-2017 | PD-L1 and tumor infiltrating lymphocytes as prognostic markers in resected NSCLC | Ameratunga, Malaka; Asadi, Khashayar ; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Knight, Simon; Mitchell, Paul L R ; Boutros, Paul; John, Thomas |
| 339 | 1-Nov-2023 | PD-L1 PET imaging in patients with NSCLC: Preliminary results of the ImmunoPET Phase 0 study. | Hegi-Johnson, Fiona; Rudd, Stacey E; Wichmann, Christian W; Akhurst, Tim; Roselt, Peter; Sursock, Sandra; Trinh, Jenny; John, Thomas ; Devereux, Lisa; Donnelly, Paul S; Hicks, Rodney J; Scott, Andrew M ; Steinfort, Daniel; Fox, Stephen; Blyth, Benjamin; Parakh, Sagun ; Hanna, Gerard G; Callahan, Jason; Burbury, Kate; MacManus, Michael |
| 340 | 9-Jun-2021 | PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma. | Parakh, Sagun ; Musafer, Ashan; Paessler, Sabrina; Witkowski, Tom ; Suen, Connie S N Li Wai; Tutuka, Candani S A; Carlino, Matteo S; Menzies, Alexander M; Scolyer, Richard A; Cebon, Jonathan S ; Dobrovic, Alexander ; Long, Georgina V; Klein, Oliver ; Behren, Andreas |
